Transphorm Inc (TGAN)

CEO:
Mario A. Rivas
Employees:
110
75 CASTILIAN DRIVE, GOLETA, CA, 93117
805-456-1300

N/A

Data derived from most recent annual or quarterly report
Market Cap 232.802 Million Shares Outstanding56.643 Million Avg 30-day Volume 52.452 Thousand
P/E Ratio0.0 Dividend Yield0.0 EPS-0.18
Price to Revenue0.0 Debt to Equity0.2905 EBITDA0
Price to Book Value4.9426 Operating Margin0.0 Enterprise Value176.012 Million
Current Ratio2.963 EPS Growth0 Quick Ratio2.43
1 Yr BETA 0.9617 52-week High/Low 7.96 / 3.38 Profit Margin0.0
Operating Cash Flow Growth0.0 Altman Z-Score2.362 Free Cash Flow to Firm 0
Earnings Report2023-05-23

View recent insider trading info

Transphorm Inc YCharts
Yahoo! Finance finviz

Funds Holding TGAN (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
Click for Additional Filters
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding TGAN

Download CSV

Active Schedule 13D and 13G filings

Please sign in first

Recent Filings

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

RIVAS MARIO CHIEF EXECUTIVE OFFICER

  • Officer
  • Director
 122,213 2023-01-01 2

MISHRA UMESH CHIEF TECHNOLOGY OFFICER

  • Officer
  • Director
 198,784 2023-01-01 4

PARIKH PRIMIT PRESIDENT AND COO

  • Officer
 233,419 2023-01-01 6

MCAULAY CAMERON CHIEF FINANCIAL OFFICER

  • Officer
 90,208 2023-01-01 2

KKR PHORM INVESTORS L.P.

KKR PHORM INVESTORS GP LLC

KKR GROUP PARTNERSHIP L.P.

KKR GROUP HOLDINGS CORP.

KKR GROUP CO. INC.

KKR & CO. INC.

KKR MANAGEMENT LLP

KRAVIS HENRY R

ROBERTS GEORGE R

  • 10% Owner
 22,675,980 2022-06-01 1

MORELAND CYNTHIA J

  • Director
 0 2021-10-20 0

SMALES KELLY

  • Director
 90,000 2021-07-01 0

MCFARLAND KATHARINA G.

  • Director
 90,000 2021-02-23 0

HUMPHREYS MICHAEL JULIAN

  • Director
 90,000 2021-02-23 0

KKR GROUP PARTNERSHIP L.P.

KKR GROUP HOLDINGS CORP.

KKR & CO. INC.

KKR MANAGEMENT LLP

KRAVIS HENRY R

ROBERTS GEORGE R

  • 10% Owner
 21,175,980 2020-09-30 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed		 Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days
No current insider transactions

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
TRANSPHORM INC TGAN 2023-03-24 22:15:03 UTC -1.1671 5.9871 800000
TRANSPHORM INC TGAN 2023-03-24 21:45:03 UTC -1.1671 5.9871 800000
TRANSPHORM INC TGAN 2023-03-24 21:15:03 UTC -1.1671 5.9871 800000
TRANSPHORM INC TGAN 2023-03-24 20:45:03 UTC -1.1671 5.9871 800000
TRANSPHORM INC TGAN 2023-03-24 20:15:04 UTC -1.1671 5.9871 800000
TRANSPHORM INC TGAN 2023-03-24 19:45:03 UTC -1.1671 5.9871 800000
TRANSPHORM INC TGAN 2023-03-24 19:15:04 UTC -1.1671 5.9871 800000
TRANSPHORM INC TGAN 2023-03-24 18:45:04 UTC -1.1671 5.9871 800000
TRANSPHORM INC TGAN 2023-03-24 18:15:03 UTC -1.1671 5.9871 800000
TRANSPHORM INC TGAN 2023-03-24 17:45:03 UTC -1.1671 5.9871 800000
TRANSPHORM INC TGAN 2023-03-24 17:15:03 UTC -1.1671 5.9871 800000
TRANSPHORM INC TGAN 2023-03-24 16:45:03 UTC -1.1528 5.9728 800000
TRANSPHORM INC TGAN 2023-03-24 16:15:03 UTC -1.1528 5.9728 800000
TRANSPHORM INC TGAN 2023-03-24 15:45:03 UTC -1.1528 5.9728 800000
TRANSPHORM INC TGAN 2023-03-24 15:15:03 UTC -1.1528 5.9728 800000
TRANSPHORM INC TGAN 2023-03-24 14:45:03 UTC -1.1528 5.9728 800000
TRANSPHORM INC TGAN 2023-03-24 14:15:03 UTC -1.1528 5.9728 800000
TRANSPHORM INC TGAN 2023-03-24 13:45:03 UTC -1.2949 5.8649 800000
TRANSPHORM INC TGAN 2023-03-24 13:15:04 UTC -1.2949 5.8649 800000
TRANSPHORM INC TGAN 2023-03-24 12:45:03 UTC -1.2949 5.8649 750000

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin
Blackstone Alternative Investment Funds- Blackstone Alternative Multi-Strategy Fund TGAN -100.0 shares, $-544.0 2022-12-31 N-PORT

No recent transactions

*** To see all congressional transactions (since 2022) for this stock, please use the congressional transaction search page***

Elevate your investments